Gene · 9436
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Dynamic changes of phenotype and function of natural killer cells in peripheral blood before and after thermal ablation of hepatitis B associated hepatocellular carcinoma and their correlation with tumor recurrence. | BMC Cancer | 2023 | 37254046 | PubTator, text mining | PubMed |
| SOX18-enforced expression diverts hemogenic endothelium-derived progenitors from T towards NK lymphoid pathways. | iScience | 2023 | 37250328 | PubTator, text mining | PubMed |
| The Important Roles of Natural Killer Cells in Liver Fibrosis. | Biomedicines | 2023 | 37239062 | PubTator, text mining | PubMed |
| Leishmaniasis: Immune Cells Crosstalk in Macrophage Polarization. | Trop Med Infect Dis | 2023 | 37235324 | PubTator, text mining | PubMed |
| Alteration of innate lymphoid cell homeostasis mainly concerns salivary glands in primary Sjögren's syndrome. | RMD Open | 2023 | 37230761 | PubTator, text mining | PubMed |
| NK cell defects: implication in acute myeloid leukemia. | Front Immunol | 2023 | 37228595 | PubTator, text mining | PubMed |
| Reciprocal costimulatory molecules control the activation of mucosal type 3 innate lymphoid cells during engagement with B cells. | Cell Mol Immunol | 2023 | 37225838 | PubTator, text mining | PubMed |
| The application of autologous cancer immunotherapies in the age of memory-NK cells. | Front Immunol | 2023 | 37205105 | PubTator, text mining | PubMed |
| The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy. | Cancers (Basel) | 2023 | 37190251 | PubTator, text mining | PubMed |
| Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas. | Int J Mol Sci | 2023 | 37176035 | PubTator, text mining | PubMed |
| Natural Killer Cells and Their Implications in Immune Response Diversification in Clinical Pathology and Neoplastic Processes. | Int J Mol Sci | 2023 | 37175450 | PubTator, text mining | PubMed |
| Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer. | Sci Rep | 2023 | 37169953 | PubTator, text mining | PubMed |
| Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors. | MAbs | 2023 | 37165468 | PubTator, text mining | PubMed |
| The single-cell transcriptional landscape of innate and adaptive lymphocytes in pediatric-onset colitis. | Cell Rep Med | 2023 | 37160121 | PubTator, text mining | PubMed |
| Towards a better understanding of human iNKT cell subpopulations for improved clinical outcomes. | Front Immunol | 2023 | 37153585 | PubTator, text mining | PubMed |
| Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques. | Front Immunol | 2023 | 37153584 | PubTator, text mining | PubMed |
| New cell sources for CAR-based immunotherapy. | Biomark Res | 2023 | 37147740 | PubTator, text mining | PubMed |
| Facing challenges with hope: universal immune cells for hematologic malignancies. | Cancer Biol Med | 2023 | 37144558 | PubTator, text mining | PubMed |
| Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? | Front Immunol | 2023 | 37143664 | PubTator, text mining | PubMed |
| Ecological niches for colorectal cancer stem cell survival and thrival. | Front Oncol | 2023 | 37124519 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9436/papers?page=16